Flagship Harbor Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Buy |
1,052
+26
| +3% | +$5.69K | 0.01% | 686 |
|
|
2025
Q1 | $230K | Buy |
+1,026
| New | +$230K | 0.01% | 669 |
|
|
2024
Q4 | – | Sell |
-795
| Closed | -$239K | – | 787 |
|
|
2024
Q3 | $239K | Buy |
+795
| New | +$239K | 0.01% | 634 |
|
|
2024
Q1 | $399K | Buy |
1,009
+327
| +48% | +$129K | 0.03% | 440 |
|
|
2023
Q4 | $240K | Sell |
682
-13
| -2% | -$4.58K | 0.02% | 547 |
|
|
2023
Q3 | $261K | Hold |
695
| – | – | 0.02% | 511 |
|
|
2023
Q2 | $266K | Sell |
695
-1,825
| -72% | -$698K | 0.02% | 506 |
|
|
2023
Q1 | $873K | Buy |
+2,520
| New | +$873K | 0.08% | 239 |
|
|
2022
Q3 | – | Sell |
-720
| Closed | -$218K | – | 624 |
|
|
2022
Q2 | $218K | Sell |
720
-33
| -4% | -$9.99K | 0.02% | 543 |
|
|
2022
Q1 | $309K | Sell |
753
-456
| -38% | -$187K | 0.03% | 473 |
|
|
2021
Q4 | $567K | Sell |
1,209
-4
| -0.3% | -$1.88K | 0.05% | 334 |
|
|
2021
Q3 | $436K | Hold |
1,213
| – | – | 0.05% | 374 |
|
|
2021
Q2 | $436K | Sell |
1,213
-10
| -0.8% | -$3.59K | 0.05% | 375 |
|
|
2021
Q1 | $345K | Buy |
1,223
+163
| +15% | +$46K | 0.04% | 438 |
|
|
2020
Q4 | $300K | Buy |
1,060
+2
| +0.2% | +$566 | 0.04% | 429 |
|
|
2020
Q3 | $290K | Buy |
1,058
+774
| +273% | +$212K | 0.04% | 375 |
|
|
2020
Q2 | $64K | Buy |
+284
| New | +$64K | 0.01% | 783 |
|
|
2018
Q4 | – | Sell |
-163
| Closed | -$20K | – | 2100 |
|
|
2018
Q3 | $20K | Sell |
163
-78
| -32% | -$9.57K | ﹤0.01% | 1122 |
|
|
2018
Q2 | $23K | Buy |
+241
| New | +$23K | ﹤0.01% | 1056 |
|